Ketorolac
Ketorolac is a powerful prescription NSAID (anti-inflammatory painkiller) used short-term to treat moderate-to-severe acute pain — usually after surgery.
🧬 Where this information comes from Click to expand
The clinical label records used on this page are FDA-filed Structured Product Labeling (SPL) retrieved through openFDA. We identified 69 clinical label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. Forms, routes, brands, labelers, strengths, and NDC product-record counts are built separately from matching FDA National Drug Code Directory records. The linked DailyMed document is a representative official source for verification, not the page’s only clinical source. View the linked label on DailyMed →
⚠️ FDA Boxed Warning — the FDA’s strongest safety alert ▾
Ketorolac carries several serious FDA boxed warnings — the highest-level safety alert. Here's what you need to know:
Short-term use only: Ketorolac is only approved for up to 5 days total. Using it longer dramatically raises the risk of life-threatening side effects. It is for moderate-to-severe acute pain — not minor pain or ongoing (chronic) conditions. It is not approved for children.
Stomach and intestinal risk: Ketorolac can cause stomach ulcers, bleeding, or a hole (perforation) in the stomach or intestines — and these can be fatal. They can happen without warning. Do not use ketorolac if you have an active ulcer or a history of GI bleeding.
Heart and stroke risk: Like all NSAIDs, ketorolac raises the risk of serious heart events like heart attack and stroke, which can also be fatal. It must not be used around the time of heart bypass (CABG) surgery.
Kidney risk: Ketorolac is contraindicated in people with severe kidney problems or those at risk of kidney failure from dehydration.
Bleeding risk: Ketorolac affects platelet function (how blood clots). It must not be used in patients with bleeding problems, suspected brain bleeding, or those at high risk of bleeding.
📖 Ketorolac: Patient Information Guide
A plain-language walkthrough of Ketorolac — what it treats, how it works, how it’s taken, side effects, warnings and interactions. Tap any section to expand it.
🎯What it's used for▾
Ketorolac is a prescription-only NSAID used for short-term management of significant acute pain. Here's when it's used:
- Moderate-to-severe acute pain — the kind that would otherwise need an opioid-level painkiller
- Postoperative pain — most commonly after surgery, when strong pain relief is needed
- Opioid-sparing therapy — it can be used alongside opioids like morphine to reduce how much opioid is needed
It is not for minor pain, chronic (long-term) conditions, or use in children.
⚙️How it works▾
Ketorolac blocks enzymes called COX-1 and COX-2 — these enzymes produce prostaglandins, which are chemicals your body releases to create pain, inflammation, and fever. By blocking this process, ketorolac reduces pain signals at the nerve level and dampens inflammation at the site of injury or surgery.
Importantly, ketorolac has no sedating or anxiety-relieving effects. Its pain relief is purely anti-inflammatory in nature. The peak pain-relieving effect kicks in within 2–3 hours of dosing.
💊How it's taken▾
Ketorolac treatment must always begin with an injection — either into a vein (IV) or a muscle (IM). Oral tablets are only used as a follow-up step if continued treatment is necessary after the injections. You cannot start treatment with the tablets alone.
- IV injections are given slowly over at least 15 seconds; IM injections go deep into the muscle
- Pain relief from an injection typically begins within about 30 minutes and lasts 4–6 hours
- A high-fat meal can slow absorption of the oral tablet slightly, though the total amount absorbed stays the same
- The total combined treatment (injections + tablets) must not exceed 5 days — switch to a different pain reliever as soon as possible
🤒Side effects — in detail▾
The most common side effects — reported in roughly 1 in 10 to 1 in 100 patients — include:
- Nausea and vomiting
- Stomach pain, heartburn, or indigestion
- Diarrhea or constipation
- Headache
- Dizziness or drowsiness
- Swelling (edema)
- Rash or itching
- Elevated liver enzymes (found on a blood test)
More serious reactions — including GI ulcers and bleeding, acute kidney failure, severe allergic reactions, liver failure, and increased bleeding — are less common but can be life-threatening. Seek immediate medical attention if you notice signs of any of these.
⚠️Warnings & precautions▾
- GI bleeding and ulcers: Ketorolac can cause fatal stomach or intestinal bleeding, ulcers, or perforation — often with no warning symptoms. Risk is higher in older adults, smokers, alcohol users, and those on steroids or blood thinners.
- Heart attack and stroke: Like all NSAIDs, ketorolac raises cardiovascular risk. This can occur early in treatment. Do not use around CABG (heart bypass) surgery.
- Kidney damage: Ketorolac can impair kidney function, especially if you are dehydrated or already have kidney problems. Dehydration should be corrected before use.
- Bleeding risk: Ketorolac reduces platelet function (how your blood clots), so bleeding may take longer to stop. It is contraindicated in patients with bleeding disorders or suspected brain hemorrhage.
- Do not exceed 5 days: Higher doses or longer use will not improve pain relief but will significantly increase the risk of all the above complications.
- Not for children: Ketorolac is not approved for pediatric patients.
🔀What it interacts with▾
Ketorolac interacts with several important medications. Always give your full medication list to your care team before starting:
- Aspirin and other NSAIDs — combining them increases the risk of serious GI bleeding and other NSAID-related harms; avoid together
- Warfarin and heparin (blood thinners) — ketorolac can amplify bleeding risk; requires very careful monitoring
- Probenecid (for gout) — contraindicated; do not use together
- Pentoxifylline (for circulation) — contraindicated; do not use together
- Corticosteroids (like prednisone) — combined use raises the risk of GI bleeding
- High-dose salicylates — can raise the level of free (active) ketorolac in the blood, increasing side effect risk
- Alcohol — increases the risk of stomach ulcers and bleeding
This is not a complete list of interactions. Always talk with your doctor or pharmacist before starting, stopping, or changing any medication.
📋Before taking it▾
- You have a current or past stomach ulcer, GI bleed, or intestinal perforation — ketorolac is contraindicated
- You have ever had an allergic reaction (asthma, hives, anaphylaxis) to aspirin or any other NSAID
- You have advanced kidney disease or are dehydrated — ketorolac is contraindicated
- You are pregnant, especially near your due date — ketorolac can harm fetal circulation and increase bleeding during labor and delivery
- You are breastfeeding — ketorolac passes into breast milk
- You are an older adult — you face a higher risk of serious GI and kidney complications
- You are scheduled for or recovering from coronary artery bypass graft (CABG) surgery — ketorolac is contraindicated in this setting
- You have a bleeding disorder, history of stroke, or cerebrovascular disease
- You have low albumin (blood protein) levels — this can increase the amount of active drug in your system
- You are taking blood thinners, other NSAIDs, steroids, probenecid, or pentoxifylline
🚑If you take too much▾
Taking too much ketorolac most often causes nausea, vomiting, stomach pain, drowsiness, and lethargy — symptoms that usually improve with supportive care. More serious but rare outcomes can include GI bleeding, high blood pressure, kidney failure, or breathing problems.
There is no specific antidote. If an overdose is suspected, seek emergency medical help immediately. Treatment is focused on managing symptoms; activated charcoal may be used if the person is seen within a few hours of ingesting a large amount.
📡Pharmacodynamics — effects in the body▾
Ketorolac relieves pain by reducing prostaglandins — chemicals that sensitize pain nerves and fuel inflammation — in the tissues where pain originates. It does not cause sedation or reduce anxiety; its entire pain-relieving action is peripheral (at the site of inflammation), not in the brain.
The peak analgesic (pain-relieving) effect occurs within 2 to 3 hours of dosing. At recommended doses, the main difference between higher and lower doses is how long the pain relief lasts, not how strong it is at its peak.
🔬Pharmacokinetics — how your body processes it▾
Ketorolac is completely absorbed when taken orally — 100% bioavailability — and this matches what you get from an injection. A high-fat meal slightly delays the peak concentration but doesn't reduce the total amount absorbed. The drug is very strongly bound to blood proteins (about 99%), and it is primarily broken down in the liver and eliminated through the urine.
Peak blood levels from an oral dose are reached in roughly 44 minutes on average. The drug follows predictable (linear) behavior at recommended doses — meaning blood levels rise proportionally with dose. Patients with low albumin (blood protein) may have more free, active drug in their system, which can increase the effect and risk of side effects.
📦How to store it▾
Store at 20° to 25°C (68° to 77°F). Protect from light.
📄 Written from Ketorolac’s FDA-approved label information, summarized in plain language with AI, and reviewed by our pharmacy team before publication. Every point is grounded in that labeling — nothing is invented. How we use AI →
Supplements & herbs that interact with Ketorolac
35 supplements and herbal products have documented interactions with Ketorolac in the licensed clinical database we use. Most are manageable — but your pharmacist should know about everything you take, including vitamins and herbals.
- Major · 5
- Moderate · 18
- Minor · 12
Educational information from a licensed clinical database (Natural Medicines) — see our data sources & update cadence. Not medical advice: an interaction being documented does not mean it will happen to you; do not start or stop medications or supplements without professional guidance.
Nutrient depletion considerations
Ketorolac has been associated with lower levels of 1 nutrient in the clinical literature. This does not mean a deficiency will occur — it means these may be worth discussing with your pharmacist or healthcare provider, especially with long-term use.
Educational information from a licensed clinical database (Natural Medicines) — not medical advice. Do not start or stop medications or supplements without professional guidance.
🩺 Pharmacist Counseling Corner
Quick, plain-English answers to the questions patients ask most about Ketorolac — the kind of thing our pharmacy team would talk through with you at the counter.
Why did my doctor give me a shot first instead of just pills? ▾
Why can I only take this for 5 days? My pain might last longer than that. ▾
What stomach warning signs should I actually watch for? ▾
I take a daily aspirin for my heart. Is it okay to take ketorolac at the same time? ▾
Can I take ketorolac if I'm pregnant or breastfeeding? ▾
Are older adults at extra risk with ketorolac? ▾
Is Ketorolac available over the counter? ▾
When was Ketorolac first available? ▾
Who makes Ketorolac? ▾
💬 Answers drafted from Ketorolac’s FDA-approved label information, summarized in plain language with AI, and reviewed by our pharmacy team before publication. Grounded in that labeling — nothing is made up. How we use AI →
🧰 Keep exploring
💊 How Ketorolac comes
Ketorolac is available in 5 forms. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.
Injection
Tablet
Eye drops
Nasal spray
Spray
📊 Ketorolac across the U.S. market
How Ketorolac appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.
FDA-listed product records by dose form (tablet variants merged) — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
Also listed with the FDA, not a patient dose form: Powder (15) · Kit (1) — bulk drug substance sold to compounders/manufacturers and multi-item kits. These aren’t counted in the dose-form total above.
Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
📈 How widely Ketorolac is used
A general measure of how commonly Ketorolac is prescribed, based on Medicaid — one of the largest public drug programs. The figure below is prescriptions filled in Q1–Q4 2025, summed across every form and brand of the drug.
Think of this as a proxy for how widely Ketorolac is used, drawn from freely available public data. Medicaid is just one program — these numbers don’t include Medicare, other government coverage, or commercial and cash-pay prescriptions, so real-world use is higher than what’s shown here.
How commonly is Ketorolac prescribed? Of the 1,596 medications we measure, Ketorolac ranks #117 by Medicaid prescriptions — more than 93% of them.
Utilization by Ketorolac product
Pick a product to see its own Medicaid numbers. Each chip is one clinical product — a specific strength & dosage form as defined by RxNorm — with brand-name and generic versions combined.
1 ML ketorolac tromethamine 30 MG/ML Injection Most dispensed
Summed across the 15 of 76 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 1665461
ketorolac tromethamine 10 MG Oral Tablet
Summed across the 9 of 250 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 834022
1 ML ketorolac tromethamine 15 MG/ML Injection
Summed across the 18 of 56 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 860092
2 ML ketorolac tromethamine 30 MG/ML Injection
Summed across the 14 of 69 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 1665459
ketorolac tromethamine 5 MG/ML Ophthalmic Solution
Summed across the 12 of 51 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 860107
ketorolac tromethamine 4 MG/ML Ophthalmic Solution
Summed across the 2 of 4 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 860103
1 ML ketorolac tromethamine 30 MG/ML Prefilled Syringe
Summed across the 2 of 4 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 860114
2 ML ketorolac tromethamine 30 MG/ML Prefilled Syringe
Summed across the 1 of 3 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 860115
ketorolac tromethamine 4.5 MG/ML Ophthalmic Solution
Summed across the 1 of 3 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 858364
Other Ketorolac products — combination packs and listings not yet matched to a specific clinical product (kept visible so every prescription is accounted for)
Summed across the 1 of 75 listed NDC products with Medicaid activity.
Shares are of the Medicaid prescriptions shown here. Product grouping follows RxNorm (the National Library of Medicine’s drug terminology), so “one product” means one strength & dosage form regardless of manufacturer. Dollar figures are gross Medicaid reimbursement before mandatory rebates — rebates (often large, especially for brand-name drugs) are confidential, so actual net cost to Medicaid is lower than shown.
Source: Medicaid State Drug Utilization Data (CMS), aggregated by generic ingredient — summed across every NDC (all brands, strengths, salt forms and dosage forms) of Ketorolac, and across all states and both fee-for-service and managed-care claims. A general popularity signal; it excludes Medicare, commercial insurance and cash prescriptions, so it is not total U.S. use. Based on the 75 of 591 listed Ketorolac NDCs with Medicaid activity.
🔍 Compare Ketorolac products
A representative set of FDA-listed product records for Ketorolac — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)
| Strength | Route | Manufacturer / Labeler | Category ⓘ | Details |
|---|---|---|---|---|
| 💊Injection | ||||
| 15 mg/mL | Intramuscular, Intravenous | A-S Medication Solutions × 2 listings | ANDA | View NDC → |
| 15 mg/mL | Intramuscular; Intravenous | A-S Medication Solutions | ANDA | View NDC → |
| 30 mg/mL | Intramuscular | A-S Medication Solutions × 2 listings | ANDA | Find on DailyMed ↗ |
| 30 mg/mL | Intramuscular, Intravenous | A-S Medication Solutions | ANDA | View NDC → |
| 30 mg/mL | Intramuscular; Intravenous | A-S Medication Solutions × 7 listings | ANDA | View NDC → |
| 60 mg/2 mL | Intramuscular, Intravenous | A-S Medication Solutions | ANDA | View NDC → |
| 60 mg/2 mL | Intramuscular; Intravenous | A-S Medication Solutions | ANDA | View NDC → |
| 60 mg/2 mL | Intramuscular | A-S Medication Solutions | ANDA | View NDC → |
| 30 mg/mL | Intramuscular, Intravenous | Advanced Rx of Tennessee, LLC × 2 listings | UNAPPROVED DRUG OTHER | View NDC → |
| 15 mg/mL | Intramuscular, Intravenous | Alembic Pharmaceuticals Inc. | ANDA | View NDC → |
| 15 mg/mL | Intramuscular; Intravenous | Alembic Pharmaceuticals Inc. × 2 listings | ANDA | View NDC → |
| 30 mg/mL | Intramuscular, Intravenous | Alembic Pharmaceuticals Inc. | ANDA | View NDC → |
| 30 mg/mL | Intramuscular; Intravenous | Alembic Pharmaceuticals Inc. × 2 listings | ANDA | View NDC → |
| 60 mg/2 mL | Intramuscular, Intravenous | Alembic Pharmaceuticals Inc. | ANDA | View NDC → |
| 60 mg/2 mL | Intramuscular; Intravenous | Alembic Pharmaceuticals Inc. × 2 listings | ANDA | View NDC → |
| 15 mg/mL | Intramuscular; Intravenous | Almaject, Inc. × 2 listings | ANDA | View NDC → |
| 30 mg/mL | Intramuscular; Intravenous | Almaject, Inc. × 2 listings | ANDA | View NDC → |
| 30 mg/mL | Intramuscular | Almaject, Inc. × 2 listings | ANDA | View NDC → |
| 30 mg/mL | Intramuscular, Intravenous | Asclemed USA, Inc. × 2 listings | UNAPPROVED DRUG OTHER | View NDC → |
| 30 mg/mL | Intramuscular; Intravenous | Asclemed USA, Inc. × 2 listings | UNAPPROVED DRUG OTHER | View NDC → |
| 60 mg/2 mL | Intramuscular | Asclemed USA, Inc. × 3 listings | ANDA | View NDC → |
| 15 mg/mL | Intramuscular; Intravenous | Athenex Pharmaceutical Division, LLC. × 2 listings | ANDA | View NDC → |
| 30 mg/mL | Intramuscular; Intravenous | Athenex Pharmaceutical Division, LLC. × 2 listings | ANDA | View NDC → |
| 15 mg/mL | Intramuscular; Intravenous | AuroMedics Pharma LLC | ANDA | View NDC → |
| 30 mg/mL | Intramuscular; Intravenous | AuroMedics Pharma LLC | ANDA | View NDC → |
| 60 mg/2 mL | Intramuscular | AuroMedics Pharma LLC | ANDA | View NDC → |
| 15 mg/2 mL | Intramuscular; Intravenous | Baxter Healthcare Corporation × 2 listings | ANDA | View NDC → |
| 15 mg/mL | Intramuscular, Intravenous | Baxter Healthcare Corporation × 2 listings | ANDA | View NDC → |
| 15 mg/mL | Intramuscular; Intravenous | Baxter Healthcare Corporation × 2 listings | ANDA | View NDC → |
| 30 mg/mL | Intramuscular, Intravenous | Baxter Healthcare Corporation × 2 listings | ANDA | View NDC → |
| 30 mg/mL | Intramuscular | Baxter Healthcare Corporation | ANDA | View NDC → |
| 30 mg/mL | Intramuscular; Intravenous | Baxter Healthcare Corporation × 2 listings | ANDA | View NDC → |
| 15 mg/mL | Intramuscular, Intravenous | Camber Pharmaceuticals, Inc. | ANDA | View NDC → |
| 15 mg/mL | Intramuscular; Intravenous | Camber Pharmaceuticals, Inc. | ANDA | View NDC → |
| 30 mg/mL | Intramuscular, Intravenous | Camber Pharmaceuticals, Inc. | ANDA | View NDC → |
| 30 mg/mL | Intramuscular; Intravenous | Camber Pharmaceuticals, Inc. | ANDA | View NDC → |
| 60 mg/2 mL | Intramuscular, Intravenous | Camber Pharmaceuticals, Inc. | ANDA | View NDC → |
| 15 mg/mL | Intramuscular, Intravenous | Caplin Steriles Limited | ANDA | View NDC → |
| 15 mg/mL | Intramuscular; Intravenous | Caplin Steriles Limited | ANDA | View NDC → |
| 30 mg/mL | Intramuscular, Intravenous | Caplin Steriles Limited | ANDA | View NDC → |
| 30 mg/mL | Intramuscular; Intravenous | Caplin Steriles Limited | ANDA | View NDC → |
| 60 mg/2 mL | Intramuscular | Caplin Steriles Limited | ANDA | View NDC → |
| 15 mg/mL | Intramuscular; Intravenous | Cardinal Health | ANDA | View NDC → |
| 30 mg/mL | Intramuscular; Intravenous | Cardinal Health | ANDA | View NDC → |
| 30 mg/mL | Intramuscular | Cardinal Health | ANDA | View NDC → |
| 15 mg/mL | Intramuscular | Cardinal Health, Inc. | ANDA | View NDC → |
| 30 mg/mL | Intramuscular | Cardinal Health, Inc. | ANDA | View NDC → |
| 15 mg/mL | Intramuscular, Intravenous | Cardinal Health 107, LLC × 2 listings | ANDA | View NDC → |
| 15 mg/mL | Intramuscular; Intravenous | Cardinal Health 107, LLC × 3 listings | ANDA | View NDC → |
| 15 mg/mL | Intramuscular | Cardinal Health 107, LLC | ANDA | View NDC → |
| 30 mg/mL | Intramuscular, Intravenous | Cardinal Health 107, LLC × 3 listings | ANDA | View NDC → |
| 30 mg/mL | Intramuscular | Cardinal Health 107, LLC × 4 listings | ANDA | View NDC → |
| 30 mg/mL | Intramuscular; Intravenous | Cardinal Health 107, LLC × 3 listings | ANDA | View NDC → |
| 15 mg/mL | Intramuscular, Intravenous | Civica, Inc. × 2 listings | ANDA | View NDC → |
| 15 mg/mL | Intramuscular; Intravenous | Civica, Inc. | ANDA | View NDC → |
| 30 mg/mL | Intramuscular, Intravenous | Civica, Inc. × 2 listings | ANDA | View NDC → |
| 30 mg/mL | Intramuscular; Intravenous | Civica, Inc. | ANDA | View NDC → |
| 30 mg/mL | Intramuscular | Direct_rx | ANDA | View NDC → |
| 15 mg/mL | Intramuscular, Intravenous | Eugia US LLC | ANDA | View NDC → |
| 15 mg/mL | Intramuscular; Intravenous | Eugia US LLC | ANDA | View NDC → |
| 30 mg/mL | Intramuscular, Intravenous | Eugia US LLC | ANDA | View NDC → |
| 30 mg/mL | Intramuscular; Intravenous | Eugia US LLC | ANDA | View NDC → |
| 60 mg/2 mL | Intramuscular | Eugia US LLC × 2 listings | ANDA | View NDC → |
| 15 mg/mL | Intramuscular, Intravenous | Fosun Pharma Usa Inc | ANDA | View NDC → |
| 15 mg/mL | Intramuscular; Intravenous | Fosun Pharma Usa Inc | ANDA | View NDC → |
| 30 mg/mL | Intramuscular | Fosun Pharma Usa Inc × 2 listings | ANDA | View NDC → |
| 30 mg/mL | Intramuscular, Intravenous | Fosun Pharma Usa Inc | ANDA | View NDC → |
| 30 mg/mL | Intramuscular; Intravenous | Fosun Pharma Usa Inc × 2 listings | ANDA | View NDC → |
| 60 mg/2 mL | Intramuscular | Fosun Pharma USA Inc | ANDA | View NDC → |
| 15 mg/mL | Intramuscular, Intravenous | Fresenius Kabi USA, LLC × 4 listings | ANDA | View NDC → |
| 15 mg/mL | Intramuscular; Intravenous | Fresenius Kabi USA, LLC × 3 listings | ANDA | View NDC → |
| 30 mg/mL | Intramuscular | Fresenius Kabi USA, LLC × 5 listings | ANDA | View NDC → |
| 30 mg/mL | Intramuscular, Intravenous | Fresenius Kabi USA, LLC × 2 listings | ANDA | View NDC → |
| 30 mg/mL | Intramuscular; Intravenous | Fresenius Kabi USA, LLC × 2 listings | ANDA | View NDC → |
| 60 mg/2 mL | Intramuscular | Fresenius Kabi USA, LLC × 2 listings | ANDA | View NDC → |
| 30 mg/mL | Intramuscular; Intravenous | General Injectables & Vaccines, Inc. | ANDA | View NDC → |
| 15 mg/mL | Intramuscular; Intravenous | General Injectables and Vaccines, Inc. | ANDA | View NDC → |
| 30 mg/mL | Intramuscular | General Injectables and Vaccines, Inc. | ANDA | View NDC → |
| 15 mg/mL | Intramuscular, Intravenous | Gland Pharma Limited | ANDA | View NDC → |
| 15 mg/mL | Intramuscular; Intravenous | Gland Pharma Limited × 3 listings | ANDA | View NDC → |
| 30 mg/mL | Intramuscular | Gland Pharma Limited × 3 listings | ANDA | View NDC → |
| 30 mg/mL | Intramuscular, Intravenous | Gland Pharma Limited | ANDA | View NDC → |
| 30 mg/mL | Intramuscular; Intravenous | Gland Pharma Limited × 3 listings | ANDA | View NDC → |
| 15 mg/mL | Intramuscular, Intravenous | Glenmark Pharmaceuticals Inc., Usa | ANDA | View NDC → |
| 15 mg/mL | Intramuscular; Intravenous | Glenmark Pharmaceuticals Inc., Usa | ANDA | View NDC → |
| 30 mg/mL | Intramuscular, Intravenous | Glenmark Pharmaceuticals Inc., Usa | ANDA | View NDC → |
| 30 mg/mL | Intramuscular; Intravenous | Glenmark Pharmaceuticals Inc., Usa | ANDA | View NDC → |
| 60 mg/2 mL | Intramuscular | Glenmark Pharmaceuticals Inc., Usa | ANDA | View NDC → |
| 15 mg/mL | Intramuscular, Intravenous | Henry Schein, Inc. | ANDA | View NDC → |
| 15 mg/mL | Intramuscular; Intravenous | Henry Schein, Inc. × 2 listings | ANDA | View NDC → |
| 30 mg/mL | Intramuscular | Henry Schein, Inc. × 4 listings | ANDA | View NDC → |
| 30 mg/mL | Intramuscular, Intravenous | Henry Schein, Inc. | ANDA | View NDC → |
| 30 mg/mL | Intramuscular; Intravenous | Henry Schein, Inc. × 3 listings | ANDA | View NDC → |
| 30 mg/mL | Intramuscular | HF Acquisition Co LLC, DBA HealthFirst × 2 listings | ANDA | View NDC → |
| 60 mg/2 mL | Intramuscular | HF Acquisition Co LLC, DBA HealthFirst | ANDA | View NDC → |
| 15 mg/mL | Intramuscular, Intravenous | Hikma Pharmaceuticals USA Inc. | ANDA | View NDC → |
| 15 mg/mL | Intramuscular; Intravenous | Hikma Pharmaceuticals USA Inc. × 2 listings | ANDA | View NDC → |
| 30 mg/mL | Intramuscular, Intravenous | Hikma Pharmaceuticals USA Inc. | ANDA | View NDC → |
| 30 mg/mL | Intramuscular | Hikma Pharmaceuticals USA Inc. × 3 listings | ANDA | View NDC → |
| 30 mg/mL | Intramuscular; Intravenous | Hikma Pharmaceuticals USA Inc. × 2 listings | ANDA | View NDC → |
| 30 mg/mL | Intramuscular, Intravenous | Medical Purchasing Solutions, LLC | ANDA | View NDC → |
| 60 mg/2 mL | Intramuscular, Intravenous | Medical Purchasing Solutions, LLC | ANDA | View NDC → |
| 30 mg/mL | Intramuscular | Nephron Pharmaceuticals Corporation | ANDA | View NDC → |
| 30 mg/mL | Intramuscular | Nephron SC Inc. | ANDA | View NDC → |
| 15 mg/mL | Intramuscular, Intravenous | Onesource Specialty Pharma Limited × 2 listings | ANDA | View NDC → |
| 30 mg/mL | Intramuscular, Intravenous | Onesource Specialty Pharma Limited × 2 listings | ANDA | View NDC → |
| 60 mg/2 mL | Intramuscular | Onesource Specialty Pharma Limited × 2 listings | ANDA | View NDC → |
| 15 mg/mL | Intramuscular, Intravenous | SOLA Pharmaceuticals, LLC | ANDA | View NDC → |
| 15 mg/mL | Intramuscular | SOLA Pharmaceuticals, LLC | ANDA | View NDC → |
| 30 mg/mL | Intramuscular, Intravenous | SOLA Pharmaceuticals, LLC × 2 listings | ANDA | View NDC → |
| 30 mg/mL | Intramuscular; Intravenous | SOLA Pharmaceuticals, LLC | ANDA | View NDC → |
| 30 mg/mL | Intramuscular, Intravenous | Sportpharm LLC | ANDA | View NDC → |
| 15 mg/mL | Intramuscular; Intravenous | Steriscience Specialties Private Limited × 2 listings | ANDA | View NDC → |
| 30 mg/mL | Intramuscular; Intravenous | Steriscience Specialties Private Limited × 2 listings | ANDA | View NDC → |
| 60 mg/2 mL | Intramuscular | Steriscience Specialties Private Limited × 2 listings | ANDA | View NDC → |
| 15 mg/mL | Intramuscular, Intravenous | Sun Pharmaceutical Industries, Inc. | ANDA | View NDC → |
| 15 mg/mL | Intramuscular; Intravenous | Sun Pharmaceutical Industries, Inc. | ANDA | View NDC → |
| 30 mg/mL | Intramuscular, Intravenous | Sun Pharmaceutical Industries, Inc. | ANDA | View NDC → |
| 30 mg/mL | Intramuscular; Intravenous | Sun Pharmaceutical Industries, Inc. | ANDA | View NDC → |
| 60 mg/2 mL | Intramuscular | Sun Pharmaceutical Industries, Inc. × 2 listings | ANDA | View NDC → |
| 15 mg/mL | Intramuscular; Intravenous | Wockhardt USA LLC. | ANDA | Find on DailyMed ↗ |
| 30 mg/mL | Intramuscular; Intravenous | Wockhardt USA LLC. | ANDA | Find on DailyMed ↗ |
Showing 200 of 479 products — FDA National Drug Code Directory. See every product, package size and price: browse all 479 Ketorolac NDCs →
📈 What people report — real-world data (FDA FAERS)
After a medicine reaches the market, patients, doctors and drugmakers can send the FDA reports of problems they think may be linked to it. Here’s what’s been reported for Ketorolac — a signal of what to watch for, not proof the drug caused it.
Source: openFDA, from the FDA Adverse Event Reporting System (FAERS). These are voluntary reports — they don’t prove the drug caused the effect, and counts reflect how often something was reported, not how often it actually happens. Reports also often name the very problem the medicine is taken for — a common reason to file one is that the drug didn’t help — so for a pain reliever you may see “pain” high on the list; that points to why the report was filed, not to the drug causing the symptom. This counts every report that lists Ketorolac in any role, so the total runs higher than the FDA’s official dashboard, which counts only cases where the drug is the suspect. For the authoritative figures, see the FDA FAERS Public Dashboard. Always talk to your pharmacist or doctor.
🏛️ The road to your pharmacy
How Ketorolac went from FDA review to the pharmacy shelf — the key milestones in its regulatory journey.
Source: Drugs@FDA.
🚨 Recall history
A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.
Source: openFDA drug enforcement (recall) reports.
RxNorm Concept Web — From Ingredient to Every Form and Strength
This page starts with one ingredient concept (IN). The branches below show its dose-form concepts (SCDF), then the available clinical drug and strength concepts (SCD). Combination products remain separate concepts with their own pages.
RxCUI 35827 7 dose forms · 15 strengths
-
Dose form (SCDF) Cartridge RxCUI 1665674No current FDA listingClinical drug / strength (SCD) 1 ML ketorolac tromethamine 15 MG/MLRxCUI 16656751 ML ketorolac tromethamine 30 MG/MLRxCUI 1665679 -
Dose form (SCDF) Injectable Solution RxCUI 372545In current FDA listingsClinical drug / strength (SCD) tromethamine 10 MG/MLRxCUI 861846tromethamine 30 MG/MLRxCUI 860096 -
Dose form (SCDF) Injection RxCUI 1665000In current FDA listingsClinical drug / strength (SCD) 1 ML ketorolac tromethamine 15 MG/MLRxCUI 8600921 ML ketorolac tromethamine 30 MG/MLRxCUI 16654612 ML ketorolac tromethamine 30 MG/MLRxCUI 1665459 -
Dose form (SCDF) Metered Dose Nasal Spray RxCUI 1797854In current FDA listingsClinical drug / strength (SCD) tromethamine 15.8 MG/ACTUATRxCUI 1797855 -
Dose form (SCDF) Ophthalmic Solution RxCUI 377446In current FDA listingsClinical drug / strength (SCD) tromethamine 4 MG/MLRxCUI 860103tromethamine 4.5 MG/MLRxCUI 858364tromethamine 5 MG/MLRxCUI 860107 -
Dose form (SCDF) Oral Tablet RxCUI 372547In current FDA listingsClinical drug / strength (SCD) tromethamine 10 MGRxCUI 834022 -
Dose form (SCDF) Prefilled Syringe RxCUI 727596No current FDA listingClinical drug / strength (SCD) 1 ML ketorolac tromethamine 15 MG/MLRxCUI 8601131 ML ketorolac tromethamine 30 MG/MLRxCUI 8601142 ML ketorolac tromethamine 30 MG/MLRxCUI 860115
Look up RxCUI 35827 in the RxCUI Atlas →
RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.
📦 Supply & shortage status
Whether Ketorolac is in short supply in the U.S. right now, plus any shortage history the FDA has on record. A shortage usually reflects a manufacturing or demand issue — not a safety problem with the drug.
Source: openFDA, from the FDA Drug Shortages database.
🏷️ Sold under these brand names
🏭 Manufacturers & labelers
…and 16 more on the FDA NDC directory.
RxNorm drug class
Ketorolac belongs to the Nonsteroidal Anti-inflammatory Drug class.
Classified by RxNorm RxClass — the U.S. National Library of Medicine's standardized drug-classification service (Established Pharmacologic Class from the FDA, the ATC drug family from the WHO, and mechanism of action). Reference only, not medical advice.
🔬 Where this comes from
Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.
How we combine label and product data
HelloPharmacist combines public FDA and NLM records; we don’t author the underlying clinical facts. We identified 69 FDA-filed SPL label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. The representative label is the starting point for the displayed reference monograph; the 12 largest stored in-scope SPL records, which may include that representative, are compared section by section, and the longest available version of each section is retained. Forms, routes, brands, labelers, product-listed strengths, and product-record counts are aggregated separately from ingredient-matched FDA NDC Directory records; package records listed above are associated with the linked SPL; and the normalized concept hierarchy comes from NLM RxNorm.
For canonical ingredient pages, bounded product-attributed indication and administration excerpts may be added to the AI evidence, and the generator is instructed to preserve available product, brand, route, and form qualifiers instead of treating one label as universal. Where a section is identified as AI-written, its plain-language text is generated from bounded label evidence. New draft drug pages remain in the admin review queue before first publication. Civica, Inc. is the representative DailyMed label linked for verification and dates; it is not the sole source used for the page.
This is general education, not medical advice — always consult your doctor or pharmacist about your medications and any medical condition. For the exact wording of the linked representative label, view that label on DailyMed; some displayed composite sections may come from other in-scope SPL labels. Learn how we use AI and our data sources & update cadence.